These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 12454816
1. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Boonsong A, Curran S, McKay JA, Cassidy J, Murray GI, McLeod HL. Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816 [Abstract] [Full Text] [Related]
2. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL. Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741 [Abstract] [Full Text] [Related]
9. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer. Murthy RV, Arbman G, Gao J, Roodman GD, Sun XF. Clin Cancer Res; 2005 Mar 15; 11(6):2293-9. PubMed ID: 15788679 [Abstract] [Full Text] [Related]
10. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG. Hepatology; 1998 Oct 15; 28(4):971-9. PubMed ID: 9755233 [Abstract] [Full Text] [Related]
11. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information. Ohrling K, Edler D, Hallström M, Ragnhammar P, Blomgren H. J Clin Oncol; 2005 Aug 20; 23(24):5628-34. PubMed ID: 16009948 [Abstract] [Full Text] [Related]
12. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy. Minardi D, Galosi AB, Giannulis I, Montironi R, Polito M, Muzzonigro G. Scand J Urol Nephrol; 2004 Aug 20; 38(1):19-25. PubMed ID: 15204422 [Abstract] [Full Text] [Related]
13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Cancer Invest; 2008 May 20; 26(4):344-51. PubMed ID: 18443954 [Abstract] [Full Text] [Related]
15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J. Anticancer Res; 2009 Feb 20; 29(2):785-91. PubMed ID: 19331236 [Abstract] [Full Text] [Related]
16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov 20; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
17. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Tzai TS, Tsai YS, Chow NH. Urol Oncol; 2004 Nov 20; 22(2):112-8. PubMed ID: 15082007 [Abstract] [Full Text] [Related]
19. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K. Anticancer Res; 2001 Nov 20; 21(4A):2357-62. PubMed ID: 11724293 [Abstract] [Full Text] [Related]
20. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance]. Li SY, Yu B, An P, Zuo FY, Cai HY. Zhonghua Wai Ke Za Zhi; 2005 Sep 01; 43(17):1118-20. PubMed ID: 16194308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]